
Sign up to save your podcasts
Or


In this Review Series episode Reflections on a Quarter Century of TKIs in CML introduced by Associate Editor Dr. Jason Gottlieb, we’ll hear from contributing authors Drs. Brian Drucker, Francois Guillot, Tim Hughes and Michael Deininger, as they discuss how CML treatment has been impacted since the introduction of tyrosine kinase inhibitors 25 years ago.
Click here to view the complete Review Series featured in Volume 145 Issue 9 of Blood.
By American Society of Hematology4.1
4949 ratings
In this Review Series episode Reflections on a Quarter Century of TKIs in CML introduced by Associate Editor Dr. Jason Gottlieb, we’ll hear from contributing authors Drs. Brian Drucker, Francois Guillot, Tim Hughes and Michael Deininger, as they discuss how CML treatment has been impacted since the introduction of tyrosine kinase inhibitors 25 years ago.
Click here to view the complete Review Series featured in Volume 145 Issue 9 of Blood.

11,155 Listeners

139 Listeners

318 Listeners

499 Listeners

75 Listeners

26 Listeners

1,156 Listeners

2 Listeners

363 Listeners

372 Listeners

1 Listeners

48 Listeners

189 Listeners

30 Listeners

4 Listeners